Association of Electronic Cigarette Use with Respiratory Symptom Development among U.S. Young Adults
Authors:
- 1 June 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 205 (11) , 1320-1329
Abstract
Rationale: Electronic cigarette (e-cigarette) use is highly prevalent among young adults. However, longitudinal data assessing the association between e-cigarette use and respiratory symptoms are lacking. Objectives: To determine whether e-cigarette use is associated with the development of respiratory symptoms in young adults. Methods: Data are derived from the PATH (Population Assessment of Tobacco and Health) study waves 2 (2014–2015), 3 (2015–2016), 4 (2016–2018), and 5 (2018–2019). Young adults aged 18–24 years at baseline with no prevalent respiratory disease or symptoms were included in the analyses. Binary logistic regression models with a generalized estimating equation were used to estimate time-varying and time-lagged associations of e-cigarette use during waves 2–4, with respiratory symptom development approximately 12 months later at waves 3–5. Measurements and Main Results: The per-wave prevalence of former and current e-cigarette use was 15.2% and 5.6%, respectively. Former e-cigarette use was associated with higher odds of developing any respiratory symptom (adjusted odds ratio [aOR], 1.20; 95% confidence interval [CI], 1.04–1.39) and wheezing in the chest (aOR, 1.41; 95% CI, 1.08–1.83) in multivariable adjusted models. Current e-cigarette use was associated with higher odds for any respiratory symptom (aOR, 1.32; 95% CI, 1.06–1.65) and wheezing in the chest (aOR, 1.51; 95% CI, 1.06–2.14). Associations persisted among participants who never smoked combustible cigarettes. Conclusions: In this nationally representative cohort of young adults, former and current e-cigarette use was associated with higher odds of developing wheezing-related respiratory symptoms, after accounting for cigarette smoking and other combustible tobacco product use.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (1K01HL154130-01)
- American Heart Association (2U54HL120163)
- American Heart Association (P50HL120163)
- American Heart Association (R01HL092577)
- American Heart Association (U54HL120163)
- American Lung Association (Public Policy Research Award)
- National Heart, Lung, and Blood Institute (1K01HL154130-01)
- American Heart Association (2U54HL120163)
- American Heart Association (P50HL120163)
- American Heart Association (R01HL092577)
- American Heart Association (U54HL120163)
- American Lung Association (Public Policy Research Award)
This publication has 52 references indexed in Scilit:
- Carbonyl Compounds in Electronic Cigarette Vapors: Effects of Nicotine Solvent and Battery Output VoltageNicotine & Tobacco Research, 2014
- Inhallation of e-Cigarette Cartridge Solution Aggravates Allergen-induced Airway Inflammation and Hyper-responsiveness in MiceToxicological Research, 2014
- Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2013
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational StudiesAnnals of Internal Medicine, 2007
- Differential Diagnosis of Adult AsthmaMedical Clinics of North America, 2006
- Smoking habit, respiratory symptoms and lung function in young adultsEuropean Journal of Public Health, 2005
- Using Generalized Estimating Equations for Longitudinal Data AnalysisOrganizational Research Methods, 2004
- Smoking on the rise among young adults: implications for research and policyTobacco Control, 2003
- Measuring the Heaviness of Smoking: using self‐reported time to the first cigarette of the day and number of cigarettes smoked per dayBritish Journal of Addiction, 1989
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986